- Home
- CVAC vs EVLV Comparison
CVAC vs EVLV Comparison
Compare CVAC & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- EVLV
- Stock Information
- Founded
- CVAC 2000
- EVLV 2013
- Country
- CVAC Germany
- EVLV United States
- Employees
- CVAC N/A
- EVLV N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- EVLV Computer peripheral equipment
- Sector
- CVAC Health Care
- EVLV Technology
- Exchange
- CVAC Nasdaq
- EVLV Nasdaq
- Market Cap
- CVAC 1.2B
- EVLV 1.4B
- IPO Year
- CVAC 2020
- EVLV N/A
- Fundamental
- Price
- CVAC $5.41
- EVLV $7.49
- Analyst Decision
- CVAC Hold
- EVLV Strong Buy
- Analyst Count
- CVAC 3
- EVLV 4
- Target Price
- CVAC $6.83
- EVLV $8.88
- AVG Volume (30 Days)
- CVAC 404.4K
- EVLV 4.4M
- Earning Date
- CVAC 11-11-2025
- EVLV 11-13-2025
- Dividend Yield
- CVAC N/A
- EVLV N/A
- EPS Growth
- CVAC N/A
- EVLV N/A
- EPS
- CVAC 1.01
- EVLV N/A
- Revenue
- CVAC $599,540,810.00
- EVLV $121,011,000.00
- Revenue This Year
- CVAC N/A
- EVLV $31.07
- Revenue Next Year
- CVAC $23.83
- EVLV $17.67
- P/E Ratio
- CVAC $5.40
- EVLV N/A
- Revenue Growth
- CVAC 675.15
- EVLV 36.64
- 52 Week Low
- CVAC $2.37
- EVLV $2.04
- 52 Week High
- CVAC $5.72
- EVLV $8.91
- Technical
- Relative Strength Index (RSI)
- CVAC 53.41
- EVLV 43.75
- Support Level
- CVAC $5.33
- EVLV $7.31
- Resistance Level
- CVAC $5.45
- EVLV $7.70
- Average True Range (ATR)
- CVAC 0.03
- EVLV 0.37
- MACD
- CVAC 0.01
- EVLV -0.12
- Stochastic Oscillator
- CVAC 66.10
- EVLV 13.57
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About EVLV Evolv Technologies Holdings Inc.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.